Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 18/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29691686 | 0.93 | CTSD (0.38) | ENPEPCTSD | |
| SCHEMBL20397486 | 0.90 | ANPEP (0.40) | ENPEPCTSD | |
| SCHEMBL31318666 | 0.88 | ENPEP (0.41) | ENPEP | |
| SCHEMBL31113634 | 0.87 | CTRB1 (0.36) | — | |
| SCHEMBL30684916 | 0.87 | LNPEP (0.42) | ENPEP | |
| SCHEMBL30536718 | 0.86 | ENPEP (0.39) | ENPEP | |
| SCHEMBL29615610 | 0.85 | CTSD (0.37) | ENPEPCTSD | |
| SCHEMBL7555807 | 0.85 | ENPEP (0.42) | ENPEPCTSD | |
| SCHEMBL29457261 | 0.85 | ENPEP (0.36) | ENPEPCTSD | |
| SCHEMBL30974548 | 0.85 | BACE1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220257698-A1 | ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER | LANTHIOPEP B.V. (NL) | 2022-08-18 | — | — | US | claimed |
| CN-114514032-A | Angiotensin type 2 (AT2) receptor agonists for the treatment of cancer | 兰提欧派普有限公司 | 2022-05-17 | — | — | CN | claimed |
| US-20220257698-A1 | ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER | LANTHIOPEP B.V. (NL) | 2022-08-18 | — | — | US | disclosed |
| CN-114514032-A | Angiotensin type 2 (AT2) receptor agonists for the treatment of cancer | 兰提欧派普有限公司 | 2022-05-17 | — | — | CN | disclosed |